{
    "2018-08-15": [
        [
            {
                "time": "",
                "original_text": "上半年超七成医药股净利润上涨 这三家药企排名前三",
                "features": {
                    "keywords": [
                        "医药股",
                        "净利润",
                        "上涨",
                        "药企"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "招商证券：上调智飞生物评级至强烈推荐",
                "features": {
                    "keywords": [
                        "招商证券",
                        "智飞生物",
                        "评级",
                        "强烈推荐"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "[推荐评级]智飞生物(300122)中报点评：HPV疫苗快速放量 业绩持续高增长",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "HPV疫苗",
                        "放量",
                        "业绩",
                        "高增长"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "智飞生物:三联苗+HPV疫苗放量,业绩超高速增长",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "三联苗",
                        "HPV疫苗",
                        "放量",
                        "业绩",
                        "高速增长"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "60股获券商买入评级 保利地产目标涨幅达119.44%",
                "features": {
                    "keywords": [
                        "券商",
                        "买入评级",
                        "保利地产",
                        "目标涨幅"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "房地产"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}